öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÕÅÐãÓ¢
ÐÔ±ð£ºÅ®
ÈËÆøÖ¸Êý£º493

ËùÊôԺУ£º¶«±±Å©Òµ´óѧ
ËùÊôԺϵ£ºË®Àû¹¤³ÌѧԺ
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£ºË¶µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º»ù´¡ÊÞҽѧ


ͨѶ·½Ê½ :
°ì¹«µç»°£º**
µç×ÓÓʼþ£ºzhangxiuying@neau.edu.cn


¿ÆÑй¤×÷ :
1.¡¶·Ç¾Æ¾«ÐÔÖ¬·¾¸ÎÔöÁ¿±í´ïCYP2A5µÄ×÷ÓûúÖƼ°Æä·¢²¡»úÖÆ¡·2011-2015,**¡£2.¹ú¼Ò×ÔÈ»»ù½ðÏîÄ¿¡¶Ö¬·¾¸Î¼°Ò©Îï¶ÔCYP2A5´úлӰÏì¼°×÷ÓûúÖÆÑо¿¡·£¬2009-2011,±àºÅ£º**£¬3.ºÚÁú½­Ê¡Áôѧ»ù½ðÏîÄ¿¡¶Ò©Îï¶ÔCYP2A5´úлµÄÓ°Ïì¡·£¬LC08C092008-20114.ºÚÁú½­Ê¡¶ÔÍâºÏ×÷ÏîÄ¿¡¶·Ö×ÓÐÞÊÎÌá¸ßÖÐÒ©¶àÌÇ¿¹²¡¶¾»îÐÔÒÑ·¢ÏÖÐÂÐÍÏȵ¼»¯ºÏÎïÑо¿¡·£¬WB08B01,2008-20115.ÊÞÒ½ÉúÎï¼¼Êõ¹ú¼ÒÖصãʵÑéÊÒ¿ª·Å»ù½ð¿ÎÌ⡶¶¯ÎïÔ´Ö²¡´ó³¦¸Ë¾ú¶àÖØÄÍÒ©ÐÔ´«²¥µÄ·Ö×Ó»úÖƼ°Æä¶Ô¾úÖ궾Á¦µÄÓ°Ïì¡·£¬2011-2012¡£6.ÊÞÓÃÈéÈûͨעÉäÒºµÄÍƹãÓë²úÒµ»¯¹Ø¼ü¼¼ÊõÑо¿£¬¿Æ¼¼²¿£¬2009-20117.¹ú¼Ò¿Æ¼¼Ö§³Å¼Æ»®¡°Ê®Ò»Î塱¹ú¼Ò¿Æ¼¼Ö§³Å¼Æ»®¿ÎÌ⡶ÊÞÓø´·½ÐÂÖƼÁµÄÑÐÖÆÓëÓ¦Óá·£¨¿ÎÌâ±àºÅ£º2006BAD31B08£©×Ó¿ÎÌ⣬¡¶¿¹ÖíÁ´Çò¾ú²¡¸´·½ÖƼÁÑо¿¡·£¬2007.12-2011.12¡£8.Nrf2ÐźÅͨ·¶ÔNAFLDСÊóÒ©Îï´úлø»ùÒò±í´ïµÄµ÷¿Ø,ºÚÁú½­Ê¡×ÔÈ»»ù½ðÖصãÏîÄ¿£¬2014-2016£¬ZD201405¡£½üÎåÄê´ú±íÐÔÖø×÷¡¢ÂÛÎÄ£º 1.LiRui,WangYuanYuan,ZhangXiuYing*.ExpressionofCytochromeP4502A5inC57BL/6Jmousemodelofnonalcoholicfattyliverdisease£¬J.Pharmacology,201392(1-2):26-31.2.R.Ll,Y.Z.Cao,Y.Y.Wang,F.P.Liu,G.F.G.Guo&X.Y.Z.ZHang¡£ExpressionofP4502A5inamousemodelofNAFLD:theidentificationofanotherpathologicalconditionofregulationCYP2A5expression¡£J.Vet.Pharamcol.Therap.35(Suppl.3)137-138.20123.XinWang,YuzhenCao,YunweiFu,GuifangGuoandXiuyingZhang*,Liverfattyacidcompositioninmicewithorwithoutnonalcoholicfattyliverdisease.Lipidinhealthanddisease.10:234:241¡£Í¨Ñ¶×÷ÕßSci£¬20114.YizheCuia,QiujuWang,XiaochongLia,XiuyingZhang*.Experimentalnonalcoholicfattyliverdiseaseinmiceleadstocytochromep4502a5upregulationthroughnuclearfactorerythroid2-like2translocation.RedoxBiology,1(2013)433¨C440.5.ChunhuaWang,YizheCui,ChunyanLi,YanhuaZhang,ShangXu,XiaochongLi,HongLiandXiuyingZhang*.Nrf2deletioncauses¡°benign¡±simplesteatosistodevelopeintononalcoholicsteatohepatitisinmicefedahigh-fatdiet.LipidsinHealthandDisease,2013,12:165.6.X.Y.ZhangandG.X.Wang.SciFour-weekoraltoxicitystudyofp-nitrophenol,p-aminophenolandp-notroanilineinrats.JournalofVeterinaryPharmacologyandTherapeutics,32£¨8£©£¬112.SCI¼ìË÷¡£7.WangG,ZhangXY*,YaoC,TianM..Four-weekoraltoxicitystudyofthreemetabolitesofnitrobenzeneinrats.DrugChemToxicol.33(3):238-43.ͨѶ×÷Õß¡£SCI,20108.WangG,ZhangXY*,YaoC,TianM¡£Acutetoxicityandmutagenesisofthreemetabolitesmixtureofnitrobenzeneinmice.ToxicolIndHealth,27(2):167-171.ͨѶ×÷Õߣ¬SCI¼ìË÷£¬20109.GuofengXu1,WeiAn2,HongdongWang1andXiuyingZhang1*Prevalenceandcharacteristicsofextended-spectrumb-lactamasegenesinEscherichiacoliisolatedfrompigletswithpost-weaningdiarrheainHeilongjiangprovince,China.FrontiersinMicrobiology,2015,6(10):1-8±àºÅ110310.YizheCui1,2QiujuWang2XingYi1XiuyingZhang1*EffectsofFattyAcidsonCYP2A5andNrf2ExpressioninMousePrimaryHepatocytes.BiochemGenet(2016)54:29¨C4011.GuofengXu1YueJiang1WeiAn2HongdongWang1XiuyingZhang1EmergenceofKPC-2-producingEscherichiacoliisolatesinanurbanriverinHarbin,China.WorldJMicrobiolBiotechnol(2015)31:1443¨C145012.ÕÅÐãÓ¢¸±Ö÷Ò룬¡¶VeterinaryPharmacologyandTherapertics¡·.¹ú¼Ò¡°Ê®¶þÎ塱ÖصãÖø×÷ÏîÄ¿¡£ÖйúÅ©Òµ³ö°æÉç¡£2012ÄêÁùÔ³ö°æ13.ÕÅÐãÓ¢£¬±àί£¬ÖлªÈËÃñ¹²ºÍ¹úÊÞÒ©µä£¨2010°æ£©£ºÊÞҩʹÓÃÖ¸ÄÏ£¨»¯Ñ§Ò©Æ·¾í£©£¬ÖйúÅ©Òµ³ö°æÉ磬2011Äê4Ô³ö°æ14.ÕÅÐãÓ¢£¬Ö÷±à£¬¶¯ÎïÒ©Îï·ÖÎö£¬ÃæÏò21ÊÀ¼Í¸ßµÈũҵԺУͳ±à½Ì²Ä£¬ÖйúÅ©Òµ³ö°æÉ磬2008Äê8Ô³ö°æ